News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

August

25

electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

Recognition highlights Truvaga’s combination of patented non-invasive vagus nerve stimulation technology, thoughtful design and...

6

electroCore Announces Second Quarter 2026 Financial Results

Second quarter 2026 net sales of $9.5 million, an increase of 28% over $7.4 million in the...

3

electroCore to Participate in Upcoming Investor Conferences

ROCKAWAY, N.J., Aug. 03, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

30

electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

ROCKAWAY, N.J., July 30, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

17

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

2

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness...

13

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

8

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

6

electroCore Announces First Quarter 2026 Financial Results

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the...

30

electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge

ROCKAWAY, N.J., April 30, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

29

electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026

ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...

28

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine...